Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Oral administration of 5-FU in a gelling nanosuspension for targeted delivery to treat colorectal cancers

Oral administration of 5-FU in a gelling nanosuspension for targeted delivery to treat colorectal cancers

US Patent 11058635 · Granted Jul 13, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

In situ gelling composition as a pH-selective and mucoadhesive sustained release2022
Oral administration of 5-FU in a gelling nanosuspension for targeted delivery to2022
Oral administration of 5-FU in a gelling nanosuspension for targeted delivery to2022
Oral administration of 5-FU in a gelling nanosuspension for targeted delivery to2022
In situ gelling composition as a pH-selective and mucoadhesive sustained release2022